– Cabozantinib in combination with atezolizumab demonstrated a statistically significant reduction in the risk of disease progression or death compared with a second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer –
– A trend toward improvement in...
Strohm, a composite pipe company, has successfully installed its first deepwater/high-pressure thermoplastic composite pipe (TCP) jumper in the Stabroek Block offshore Guyana. The installation marks the adoption of Strohm's innovative "Jumper on Demand" approach and its effectiveness in enhancing...
Guyana’s Minister of Natural Resources has revealed that the government agreed to let Exxon unitise the Liza and Payara fields, a step to allow a floating production, storage and offloading (FPSO) vessel from one field to tap oil from...
Russia’s invasion of Ukraine foisted Europe to the top as one of the largest buyers of Guyana’s Liza and Unity Gold crude, said S&P Global Commodity Insights' oil pricing and news expert Patrick Harrington.
“Until recently, the bulk of Guyana...
· FF has successfully completed all compliance testing in anticipation of the delivery of the FF 91 2.0 Futurist Alliance, marking another important milestone for FF of delivering to the first group of its users who have joined FF's...
The OSV Horn Island vessel will be continuing deepwater development at Guyana’s Liza Field located in the offshore Stabroek Block.
A recent notice by the Maritime Administration Department (MARAD) outlined that activities will conclude at the site on December 31.
The...
ExxonMobil, Hess and CNOOC have managed to recover more than US$10 billion in investments so far, to explore and develop the prolific Stabroek Block.
The Stabroek Block Production Sharing Agreement (PSA) allows the partners to recover investments by taking up...
- The Company continues to assess the full dataset; daxdilimab trials in alopecia areata, discoid lupus erythematosus and lupus nephritis ongoing –DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that its Phase 2 clinical trial evaluating daxdilimab for the...
– First Clinical Study of a Central Nervous System-Administered RNAi Therapeutic Showed Rapid and Robust Target Engagement with Sustained Effect Over 6 Months with a Single Dose –
– ALN-APP Continues to Demonstrate an Encouraging Clinical Safety and Tolerability Profile...
Gas remains key to ExxonMobil’s development agenda as seen by the company’s acceleration of two major pipeline projects in the South American region.
Over in Argentina, Exxon recently commenced the engineering study phase for the development of a new pipeline...